Compounds and methods for modulating cerebral amyloid angiopathy

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 6670399
APP PUB NO 20030003141A1
SERIAL NO

09747408

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention provides methods of inhibiting cerebral amyloid angiopathy. The invention further provides methods of treating a disease state characterized by cerebral amyloid angiopathy in a subject with an A.beta.40 inhibitor having the structure: Q-[--SO.sub.3.sup.- X.sup.+ ].sub.n or Q-[--OSO.sub.3.sup.- X.sup.+].sub.n wherein Q is a carrier group; X+ is a cationic group; and n is one.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
BELLUS HEALTH (INTERNATIONAL) LIMITEDFEDERAL POLYTECHNICAL SCHOOL AT LAUSANNE SCIENCE PARK LAUSANNE CH-1015

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Gervais, Francine Ile Bizard, CA 31 836
Green, Allan M Cambridge, MA 19 254

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation